SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Don't Blame Me, I Voted For Kerry -- Ignore unavailable to you. Want to Upgrade?


To: Nicholas Thompson who wrote (79316)9/14/2006 7:58:42 PM
From: TimFRead Replies (1) | Respond to of 81568
 
Many other countries are effectively subsidized by the US for their prescription drug purchases. The majority of the profit is in the US since we don't control prices. That profit motivates new drug research. We could effectively drop this subsidy and otherwise lower costs by limiting drug pricing but than you will get much less drug research.

Other reasons for health care being more expensive in the US is that most other countries ration care to a greater extent. The truly rich can get tons of expensive care almost anywhere (even if their country mandates the use of the state system they leave the country unless it also prohibits such action) but that goes further down the ladder in the US than under socialized health care systems.

None of which means I think the US has a good system. I just don't think that political allocation of resources is likely to result in a cheaper or better system. (In fact to the extent its already happened in the US its probably made our system worse). We aren't going to make medical school a lot cheaper if we put in place something like Medicare for everyone. We're unlikely to get doctors to accept much lower compensation (they do get lower compensation in most other countries), we aren't going to get someone else to subsidize our drug market so either we accept less drug development or the high prices that we have.